Key Events This Week
13 Apr: New 52-week and all-time high at Rs.1,027
15 Apr: New 52-week and all-time high at Rs.1,091.9
16 Apr: New 52-week and all-time high at Rs.1,119, followed by a slight pullback
17 Apr: Week closes at Rs.1,042.35 (+0.31%)
Monday, 13 April: New 52-Week and All-Time Highs Spark Momentum
Venus Remedies Ltd began the week on a strong note, hitting a new 52-week high of Rs.1,027 and an all-time high closing price of Rs.1,024.35. The stock gained 4.61% intraday and closed up 1.83%, significantly outperforming the Sensex which declined 0.76% that day. This surge was driven by the company’s robust financial performance, including a 96.37% growth in operating profit and a 116.9% increase in quarterly PAT to Rs.25.58 crores. The stock’s technical indicators, including bullish MACD and Bollinger Bands, supported this upward momentum. Institutional investors increased their stake by 0.72%, reflecting growing confidence.
Wednesday, 15 April: Venus Remedies Hits Rs.1,091.9, Extending Rally
The stock continued its upward trajectory, reaching a new 52-week and all-time high of Rs.1,091.9. Venus Remedies gained 2.58% on the day, outperforming the Sensex’s 1.89% rise. This marked the fifth consecutive day of gains, with a cumulative return of over 17% in this period. The company’s strong fundamentals, including a zero debt-to-equity ratio and efficient asset utilisation with an inventory turnover ratio of 6.58 times, underpinned investor enthusiasm. Technical signals remained bullish, with the stock trading above all key moving averages.
Transformation in full progress! This Micro Cap from Auto Ancillary just achieved sustainable profitability after tough times. Be early to witness this powerful comeback story!
- - Sustainable profitability reached
- - Post-turnaround strength
- - Comeback story unfolding
Thursday, 16 April: New Peak at Rs.1,119 Followed by Mild Pullback
Venus Remedies Ltd reached a fresh 52-week and all-time high of Rs.1,119, marking a significant milestone with a gain of 4.89% intraday. However, the stock closed lower by 2.60%, reflecting a mild profit-taking after a strong rally. Despite this pullback, the stock remained well above all major moving averages, maintaining a bullish technical stance. The Sensex showed mixed signals, closing up 0.26%. The company’s consistent earnings growth, with five consecutive quarters of positive results, and a strong return on capital employed of 13.99%, continue to support the stock’s fundamentals. Institutional holdings remain steady at 4%.
Friday, 17 April: Week Ends with Modest Gain Amid Market Strength
Venus Remedies closed the week at Rs.1,042.35, up 0.31% on the day, consolidating gains after the previous day’s pullback. The Sensex rose 0.94%, reflecting broader market optimism. Trading volume was lower, indicating a pause in momentum as investors digested the week’s strong price action. The stock’s valuation remains attractive with a PEG ratio of 0.10 and a P/E ratio around 17-19 times, supported by robust earnings growth. Delivery volumes have surged over the past month, signalling sustained investor interest.
Curious about Venus Remedies Ltd from ? Get the complete picture with our detailed research report covering fundamentals, technicals, peer analysis, and everything you need to decide!
- - Detailed research coverage
- - Technical + fundamental view
- - Decision-ready insights
Daily Price Performance: Venus Remedies Ltd vs Sensex
| Date | Stock Price | Day Change | Sensex | Day Change |
|---|---|---|---|---|
| 2026-04-13 | Rs.1,039.95 | +4.61% | 34,738.75 | -0.76% |
| 2026-04-15 | Rs.1,066.80 | +2.58% | 35,394.87 | +1.89% |
| 2026-04-16 | Rs.1,039.10 | -2.60% | 35,485.91 | +0.26% |
| 2026-04-17 | Rs.1,042.35 | +0.31% | 35,820.15 | +0.94% |
Key Takeaways from the Week
Strong Price Momentum: Venus Remedies Ltd demonstrated robust price appreciation, gaining 4.85% over the week and outperforming the Sensex’s 2.33% rise. The stock hit multiple new 52-week and all-time highs, reflecting sustained investor enthusiasm.
Robust Financial Performance: The company’s latest quarterly results showed a 96.37% increase in operating profit and a 116.9% rise in PAT, underpinning the stock’s rally. Five consecutive quarters of positive results highlight operational consistency.
Technical Strength: The stock traded above all major moving averages with bullish MACD and Bollinger Bands indicators on weekly and monthly charts, signalling continued upward momentum despite a minor pullback on 16 April.
Institutional Confidence: Institutional investors increased their stake by 0.72% last quarter, now holding 4%, indicating growing confidence in the company’s fundamentals and growth prospects.
Valuation and Growth Considerations: With a PEG ratio of 0.10 and a P/E ratio near 17-19 times, the stock remains attractively valued relative to its earnings growth. However, the company’s moderate long-term sales growth rate of 6.29% warrants monitoring for sustained top-line expansion.
Conclusion
Venus Remedies Ltd’s performance during the week ending 17 April 2026 highlights a company in strong operational and market form. The stock’s multiple new highs, supported by impressive financial results and positive technical indicators, underscore its resilience and growth potential within the Pharmaceuticals & Biotechnology sector. While a slight pullback on 16 April suggests some short-term consolidation, the overall trend remains bullish. Growing institutional participation and attractive valuation metrics further reinforce the stock’s appeal. Investors should continue to monitor the company’s revenue growth alongside its profitability to assess the sustainability of this momentum in the coming months.
Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Start Today
